Latest filings from the Hong Kong Stock Exchange reveal that on September 8, Southern Fund increased its position in Asymchem Laboratories (Tianjin) Co., Ltd. (HKEX: 06821) by 25,000 shares.
The shares were acquired at an average price of HK$140.2468 each, bringing the total transaction value to approximately HK$3.506 million.
Following this latest purchase, Southern Fund's total holdings in the company now stand at 1.4048 million shares, representing a 5.05% stake in the pharmaceutical giant.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.